# Hint Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hint-biotech

- Industry: Biotechnology
- Headquarters: Jiaxing, China
- Latest round: Angel (Jul 31, 2023)
- Investors on record: 1

## About

Based in Jianing, China, and founded in 2023, Hint Biotech is a biopharmaceutical company dedicated to nano-antibody diagnostic and therapeutic biopharmaceutical research and development. In July 2023, Hint Biotech raised an undisclosed amount of angel funding from new investor Goldport Capital.

The company is committed to nano-antibody diagnostic and therapeutic innovative biopharmaceutical research and development in the field of oncology, immune diseases, infectious diseases, and molecular imaging. It has developed 4 technology platforms, including a nano-antibody drug discovery platform, an integrated structural biology platform, a recombinant protein expression and purification platform, and a biophysical characterization platform, which covers a full set of nano-antibody immunization, screening, production, and characterization technologies.

The company will use the funds for drug candidate screening, structure optimization, preclinical validation, differentiated nanoantibody technology platform, team building, market channel expansion, company operation, etc.

## Funding rounds

- Angel, Jul 31, 2023 — Goldport Capital

## Investors

- Goldport Capital (https://capitalatlas.ai/funds/goldport-capital) — Angel
